Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial

by Sandrine Micallef, Alexandre Sostelly, Jiawen Zhu, Paul G. Baverel, Francois Mercier
Published 2022-04-01

MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma.

by Ludovic Lacroix, Sophie F Post, Alexander Valent, Antoine E Melkane, Philippe Vielh, Coumaran Egile, Christelle Castell, Christelle Larois, Sandrine Micallef, Patrick Saulnier, Hélène Goulaouic, Anne-Marie Lefebvre, Stéphane Temam
Published 2014-01-01

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients

by Cary M. Looney, MS, Aaron Schroeder, BS, Erica Tavares, BSN, Jay Garg, MD, MBA, Thomas Schindler, PhD, Flavio Vincenti, MD, Robert R. Redfield, MD, Stanley C. Jordan, MD, Stephan Busque, MD, E. Steve Woodle, MD, Jared Khan, MS, Jeffrey Eastham, MS, Sandrine Micallef, PhD, Cary D. Austin, MD, PhD, Alyssa Morimoto, PhD
Published 2023-02-01